Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders (ATLAS)

April 23, 2013 updated by: Gerhard Andersson, Linkoeping University

Internet-delivered Psychodynamic Therapy for Depression and Anxiety Disorders: A Randomized Controlled Trial

The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with major depression and/or anxiety disorders and compare its efficacy to an active control group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
      • Linköping, Sweden, 58183
        • Linköping University, Department of Behavioral Sciences and Learning

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, Generalized Anxiety disorder, Depressive Disorder NOS or Anxiety Disorder NOS
  • 10 or higher on the PHQ-9 or on the GAD-7 at pre-treatment

Exclusion Criteria:

  • Primary diagnosis of Obsessive Compulsive Disorder or Post-traumatic Stress Disorder
  • Severe psychiatric condition (e.g. psychosis or bipolar disorder)
  • Alcohol abuse (more than 16 on the AUDIT)
  • Suicidal (measured in diagnostic interview)
  • Changed medication during the last three months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Internet-delivered Psychodynamic Treatment
Participants in the experimental condition will receive 8 text-modules delivered as guided self-help, via the Internet. The intervention lasts for 10 weeks and includes weekly contacts with a therapist via a secure online environment similar to e-mail. The treatment is a short-term psychodynamic treatment psychodynamic treatment.
Behavioral: Internet-delivered Psychodynamic Treatment
Ten weeks of guided self-help + therapist contact, via the Internet.
Active Comparator: Internet-delivered structured support
Participants in the active control condition will receive a structured support treatment via the Internet. The intervention lasts for 10 weeks and includes weekly contacts with a therapist via a secure online environment similar to e-mail.
Behavioral: Internet-delivered structured support
Ten weeks of therapist contact, via the Internet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
9-item Patient Health Questionnaire Depression Scale (PHQ-9)
Time Frame: Two weeks before the treatment starts
Two weeks before the treatment starts
7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
Time Frame: Two weeks before the treatment starts
Two weeks before the treatment starts
9-item Patient Health Questionnaire Depression Scale (PHQ-9)
Time Frame: At treatment start (0 weeks)
At treatment start (0 weeks)
7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
Time Frame: At treatment start (0 weeks)
At treatment start (0 weeks)
9-item Patient Health Questionnaire Depression Scale (PHQ-9)
Time Frame: At treatment termination (10 weeks)
At treatment termination (10 weeks)
7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
Time Frame: At treatment termination (10 weeks)
At treatment termination (10 weeks)
9-item Patient Health Questionnaire Depression Scale (PHQ-9)
Time Frame: At treatment follow-up (7 months)
At treatment follow-up (7 months)
7-item Patient Health Questionnaire Generalized Anxiety Disorder Scale (GAD-7)
Time Frame: At treatment follow-up (7 months)
At treatment follow-up (7 months)

Secondary Outcome Measures

Outcome Measure
Time Frame
Emotional Processing Scale (EPS-25)
Time Frame: Two weeks before the treatment starts
Two weeks before the treatment starts
Emotional Processing Scale (EPS-25)
Time Frame: At treatment start (0 weeks)
At treatment start (0 weeks)
Emotional Processing Scale (EPS-25)
Time Frame: At treatment termination (10 weeks)
At treatment termination (10 weeks)
Five Facets of Mindfulness Questionnaire (FFMQ)
Time Frame: Two weeks before the treatment starts
Two weeks before the treatment starts
Five Facets of Mindfulness Questionnaire (FFMQ)
Time Frame: At treatment start (0 weeks)
At treatment start (0 weeks)
Five Facets of Mindfulness Questionnaire (FFMQ)
Time Frame: At treatment termination (10 weeks)
At treatment termination (10 weeks)
Emotional Processing Scale (EPS-25)
Time Frame: At treatment follow-up (7 months)
At treatment follow-up (7 months)
Five Facets of Mindfulness Questionnaire (FFMQ)
Time Frame: At treatment follow-up (7 months)
At treatment follow-up (7 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Linkoeping University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

February 9, 2012

First Submitted That Met QC Criteria

February 9, 2012

First Posted (Estimate)

February 14, 2012

Study Record Updates

Last Update Posted (Estimate)

April 24, 2013

Last Update Submitted That Met QC Criteria

April 23, 2013

Last Verified

April 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GA-DEPANX2012-APT

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Internet-delivered Psychodynamic Treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe